HNN3.0
Register
Register
Register

Project cooperationUpdated on 6 January 2026

Enhancing Novel Vaccine Candidate Production Yields

External Scientific Program Manager at Virica Biotech

Ottawa, Canada

About

Virica is looking to join a consortium working towards the development and manufacturing of a novel vaccine candidate.

Virica's Viral Sensitizers (VSE™) are small-molecule media additives that temporarily dampen host-cell defenses, enhancing viral yields and quality across diverse manufacturing platforms. Beyond supplying VSEs as off-the-shelf reagents, Virica operates as a fast-turnaround service partner: our proprietary High-Throughput Virology (HTV™) platform, Design-of-Experiments (DoE) process optimization, and analytical testing workflows let developers rapidly pinpoint the best production conditions so programs can move to scale sooner and at lower cost.

We are looking to participate by contributing our small molecule enhancer technology, coupled with small scale process development expertise and high-throughput screening capabilities to optimize production of new vaccine candidates.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential

Type

  • Partner seeks Consortium/Coordinator

Organisation

Virica Biotech

Company (SME)

Ottawa, Canada

Similar opportunities

  • Project cooperation

    Protein design, modelling, optimisation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential

    Abdullah Kahraman

    Professor of Data Science in Life Sciences at School of Life Sciences, University of Applied Sciences Northwestern Switzerland

    Muttenz, Switzerland

  • Project cooperation

    Offering expertise in tailored antiviral strategies and viral models generation

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential

    Ilaria Carli

    Principal Research Scientist at IRBM S.p.A.

    Rome, Italy

  • Project cooperation

    Novel "Innate" Approaches for Vaccines in Low- and Middle-Income Countries

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential

    Fabrizio Chiodo

    Associate Professor (Italian National Research Council) at Consiglio Nazionale delle Ricerche

    Palermo, Italy